New mechanisms of pulmonary arterial hypertension: Role of Ca 2+signaling

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 302, Issue 8, 2012, Pages

  Kuhr, Frank K ^a   Smith, Kimberly A ^a   Song, Michael Y ^a   Levitan, Irena ^a   Yuan, Jason X J ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Calcium channel; Calcium regulation; Canonical transient receptor potential channel; Vascular remodeling; Vasoconstriction

Indexed keywords

ACTIVIN RECEPTOR LIKE KINASE 1; CALCINEURIN; CALCIUM; CALCIUM CHANNEL; CAVEOLIN; CAVEOLIN 1; CAVEOLIN 2; CAVEOLIN 3; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; ENDOGLIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ION CHANNEL; MITOGEN ACTIVATED PROTEIN KINASE; POTASSIUM CHANNEL; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR NFAT; TRANSIENT RECEPTOR POTENTIAL CHANNEL; TRANSIENT RECEPTOR POTENTIAL CHANNEL 6;

ALTITUDE; APOPTOSIS; CALCIUM SIGNALING; CAVEOLA; CHRONIC KIDNEY FAILURE; CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION; CONGENITAL HEART DISEASE; CONNECTIVE TISSUE DISEASE; DIASTOLIC DYSFUNCTION; DISEASE ASSOCIATION; DISEASE COURSE; DYSPNEA; FATIGUE; GAUCHER DISEASE; GENE INTERACTION; GLYCOGEN STORAGE DISEASE; HEART OUTPUT; HEART RIGHT VENTRICLE FAILURE; HEMATOLOGIC DISEASE; HEMOLYTIC ANEMIA; HISTIOCYTOSIS X; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IDIOPATHIC DISEASE; INTERSTITIAL LUNG DISEASE; LUNG DISEASE; LYMPHANGIOLEIOMYOMATOSIS; MEDIASTINITIS; MYELOPROLIFERATIVE DISORDER; NEUROFIBROMATOSIS; NONHUMAN; PORTAL HYPERTENSION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PULMONARY ARTERY; PULMONARY HYPERTENSION; RENDU OSLER WEBER DISEASE; REVIEW; SARCOIDOSIS; SCHISTOSOMIASIS; SLEEP DISORDERED BREATHING; SMOOTH MUSCLE FIBER; SPLENECTOMY; SYSTOLIC DYSFUNCTION; THYROID DISEASE; UPREGULATION; VALVULAR HEART DISEASE; VASCULITIS; VASOCONSTRICTION;

ANIMALS; APOPTOSIS; CALCIUM; CALCIUM CHANNELS; CALCIUM SIGNALING; CARRIER PROTEINS; CAVEOLAE; CAVEOLINS; CELL PROLIFERATION; HOMEODOMAIN PROTEINS; HUMANS; HYPERTENSION, PULMONARY; MYOCYTES, SMOOTH MUSCLE; POTASSIUM CHANNELS; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TRANSIENT RECEPTOR POTENTIAL CHANNELS; VASOCONSTRICTION;

EID: 84858306938     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00944.2011     Document Type: Review

References (147)

1. - currents by phosphorylation in pulmonary arterial smooth muscle cells. J Gen Physiol 128: 73-87, 2006.
2. Archer S, Rich S. Primary pulmonary hypertension: a vascular biology and translational research "Work in progress". Circulation 102: 2781-2791, 2000.
3. Archer SL, Souil E, Dinh-Xuan AT, Schremmer B, Mercier JC, El Yaagoubi A, Nguyen-Huu L, Reeve HL, Hampl V. Molecular identification of the role of voltage-gated K channels, Kv1.5 and Kv21, in hypoxic pulmonary vasoconstriction and control of resting membrane potential in rat pulmonary artery myocytes. J Clin Invest 101: 2319-2330, 1998.
4. Archer SL, Wu XC, Thebaud B, Nsair A, Bonnet S, Tyrrell B, McMurtry MS, Hashimoto K, Harry G, Michelakis ED. Preferential expression and function of voltage-gated, O2-sensitive K channels in resistance pulmonary arteries explains regional heterogeneity in hypoxic pulmonary vasoconstriction: ionic diversity in smooth muscle cells. Circ Res 95: 308-318, 2004.
5. Atkinson NS, Robertson GA, Ganetzky B. A component of calcium-activated potassium channels encoded by the Drosophila slo locus. Science 253: 551-555, 1991.
6. Badesch DB, Champion HC, Sanchez MA, Hoeper MM, Loyd JE, Manes A, McGoon M, Naeije R, Olschewski H, Oudiz RJ, Torbicki A. Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol 54: S55-S66, 2009.
7. Badesch DB, Raskob GE, Elliott CG, Krichman AM, Farber HW, Frost AE, Barst RJ, Benza RL, Liou TG, Turner M, Giles S, Feldkircher K, Miller DP, McGoon MD. Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry. Chest 137: 376-387, 2010.
8. Bedford DE, Evans W, Short DS. Solitary pulmonary hypertension. Br Heart J 19: 93-116, 1957.
9. Beech DJ, Xu SZ, McHugh D, Flemming R. TRPC1 store-operated cationic channel subunit. Cell Calcium 33: 433-440, 2003.
10. Benza RL, Gomberg-Maitland M, Miller DP, Frost A, Frantz RP, Foreman AJ, Badesch DB, McGoon MD. The REVEAL risk score calculator in newly diagnosed patients with pulmonary arterial hypertension. Chest 2011 Jun 16. [Epub ahead of print]
11. Berridge MJ. Calcium signalling and cell proliferation. Bioessays 17: 491-500, 1995.
12. Berridge MJ. Inositol trisphosphate and calcium signalling. Nature 361: 315-325, 1993.
13. Berridge MJ, Bootman MD, Roderick HL. Calcium signalling: dynamics, homeostasis and remodelling. Nat Rev Mol Cell Biol 4: 517-529, 2003.
14. Bers DM, Guo T. Calcium signaling in cardiac ventricular myocytes. Ann NY Acad Sci 1047: 86-98, 2005.
15. Bonnet S, Paulin R, Sutendra G, Dromparis P, Roy M, Watson KO, Nagendran J, Haromy A, Dyck JR, Michelakis ED. Dehydroepiandro-sterone reverses systemic vascular remodeling through the inhibition of the Akt/GSK3-p/NFAT axis. Circulation 120: 1231-1240, 2009.
16. Bortner CD, Cidlowski JA. Volume regulation and ion transport during apoptosis. Methods Enzymol 322: 421-433, 2000.
17. Brayden JE, Nelson MT. Regulation of arterial tone by activation of calcium-dependent potassium channels. Science 256: 532-535, 1992.
18. 2+ influx channels by regulating plasma membrane localization of TRPC1. J Biol Chem 278: 27208-27215, 2003.
19. Brevnova EE, Platoshyn O, Zhang S, Yuan JX. Overexpression of human KCNA5 increases Ik(V) and enhances apoptosis. Am JPhysiol Cell Physiol 287: C715-C722, 2004.
20. 2+ entry. Nat Cell Biol 11: 669-677, 2009.
21. Cahalan MD, Zhang SL, Yeromin AV, Ohlsen K, Roos J, Stauder-man KA. Molecular basis of the CRAC channel. Cell Calcium 42: 133-144, 2007.
22. Chen TT, Luykenaar KD, Walsh EJ, Walsh MP, Cole WC. Key role of Kv1 channels in vasoregulation. Circ Res 99: 53-60, 2006.
23. Clapham DE. Intracellular calcium. Replenishing the stores. Nature 375: 634-635, 1995.
24. Clapham DE. TRP channels as cellular sensors. Nature 426: 517-524, 2003.
25. Clapp LH, Gurney AM. Modulation of calcium movements by nitro-prusside in isolated vascular smooth muscle cells. Pflugers Arch 418: 462-470, 1991.
26. Cool CD, Stewart JS, Werahera P, Miller GJ, Williams RL, Voelkel NF, Tuder RM. Three-dimensional reconstruction of pulmonary arteries in plexiform pulmonary hypertension using cell-specific markers. Evidence for a dynamic and heterogeneous process of pulmonary endothelial cell growth. Am J Pathol 155: 411-419, 1999.
27. Courboulin A, Paulin R, Giguere NJ, Saksouk N, Perreault T, Meloche J, Paquet ER, Biardel S, Provencher S, Cote J, Simard MJ, Bonnet S. Role for miR-204 in human pulmonary arterial hypertension. J Exp Med 208: 535-548, 2011.
28. Cowan KN, Jones PL, Rabinovitch M. Elastase and matrix metallo-proteinase inhibitors induce regression, and tenascin-C antisense prevents progression, of vascular disease. J Clin Invest 105: 21-34, 2000.
29. 2+ channels in vascular smooth muscle: multiple functions. Cell Calcium 40: 221-230, 2006.
30. 2+/calmodulin-dependent protein kinase type IV expressed in insect cells. J Biol Chem 268: 26171-26178, 1993.
31. Dawson CA. Hypoxic pulmonary vasoconstriction: heterogeneity. In: Hypoxic Pumonary Vasoconstriction: Cellular and Molecular Mechanisms, edited by Yuan JX. Boston, MA: Kluwer Academic, 2004, p. 15-33.
32. 2+ response amplitude and duration. Nature 386: 855-858, 1997.
33. Durmowicz AG, Parks WC, Hyde DM, Mecham RP, Stenmark KR. Persistence, re-expression, and induction of pulmonary arterial fibronec-tin, tropoelastin, and type I procollagen mRNA expression in neonatal hypoxic pulmonary hypertension. Am J Pathol 145: 1411-1420, 1994.
34. Firth AL, Mandel J, Yuan JX. Idiopathic pulmonary arterial hypertension. Dis Model Mech 3: 268-273, 2010.
35. Firth AL, Remillard CV, Platoshyn O, Fantozzi I, Ko EA, Yuan JX. Functional ion channels in human pulmonary artery smooth muscle cells: Voltage-dependent cation channels. Pulm Circ 1: 48-71, 2011.
36. Fleischmann BK, Murray RK, Kotlikoff MI. Voltage window for sustained elevation of cytosolic calcium in smooth muscle cells. Proc Natl Acad Sci USA 91: 11914-11918, 1994.
37. Floyd R, Wray S. Calcium transporters and signalling in smooth muscles. Cell Calcium 42: 467-476, 2007.
38. Forrest AS, Angermann JE, Raghunathan R, Lachendro C, Greenwood IA, Leblanc N. Intricate interaction between store-operated calcium entry and calcium-activated chloride channels in pulmonary artery smooth muscle cells. Adv Exp Med Biol 661: 31-55, 2010.
39. Fox AP, Nowycky MC, Tsien RW. Single-channel recordings of three types of calcium channels in chick sensory neurones. J Physiol 394: 173-200, 1987.
40. Frost AE, Badesch DB, Barst RJ, Benza RL, Elliott CG, Farber HW, Krichman A, Liou TG, Raskob GE, Wason P, Feldkircher K, Turner M, McGoon MD. The changing picture of patients with pulmonary arterial hypertension in the United States: how REVEAL differs from historic and non-US Contemporary Registries. Chest 139: 128-137, 2010.
41. Gabella G. Quantitative morphological study of smooth muscle cells of the guinea-pig taenia coli. Cell Tissue Res 170: 161-186, 1976.
42. 2+ entry in human pulmonary artery myocytes during proliferation. Am J Physiol Heart Circ Physiol 280: H746-H755, 2001.
43. 2+/calcineurin and NFATc3/c4 pattern the developing vasculature. Cell 105: 863-875, 2001.
44. Gurney AM, Joshi S, Manoury B. KCNQ potassium channels: new targets for pulmonary vasodilator drugs? Adv Exp Med Biol 661: 405417, 2010.
45. Hardingham GE, Bading H. Nuclear calcium: a key regulator of gene expression. Biometals 11: 345-358, 1998.
46. Hardingham GE, Chawla S, Johnson CM, Bading H. Distinct functions of nuclear and cytoplasmic calcium in the control of gene expression. Nature 385: 260-265, 1997.
47. Huang W, Yen RT, McLaurine M, Bledsoe G. Morphometry of the human pulmonary vasculature. J Appl Physiol 81: 2123-2133, 1996.
48. + suppresses the activation of apoptosis in lymphocytes. J Biol Chem 272: 30567-30576, 1997.
49. Humbert M, Sitbon O, Chaouat A, Bertocchi M, Habib G, Gressin V, Yaici A, Weitzenblum E, Cordier JF, Chabot F, Dromer C, Pison C, Reynaud-Gaubert M, Haloun A, Laurent M, Hachulla E, Simonneau Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med 173: 1023-1030, 2006.
50. 2+ exchanger type-1 in vascular smooth muscle. Nat Med 10: 1193-1199, 2004.
51. Jackson WF. Ion Channels and Vascular Tone. Hypertension 35: 173-178, 2000.
52. Johnson SR, Granton JT, Mehta S. Thrombotic arteriopathy and anticoagulation in pulmonary hypertension. Chest 130: 545-552, 2006.
53. Joshi S, Balan P, Gurney AM. Pulmonary vasoconstrictor action of KCNQ potassium channel blockers. Respir Res 7: 31, 2006.
54. Joshi S, Sedivy V, Hodyc D, Herget J, Gurney AM. KCNQ modulators reveal a key role for KCNQ potassium channels in regulating the tone of rat pulmonary artery smooth muscle. J Pharmacol Exp Ther 329: 368-376, 2009.
55. Ju M, Shi J, Saleh SN, Albert AP, Large WA. Ins(1,4,5)P3 interacts with PIP2 to regulate activation of TRPC6/C7 channels by diacylglycerol in native vascular myocytes. J Physiol 588: 1419-1433, 2010.
56. Kahl CR, Means AR. Regulation of cell cycle progression by calcium/ calmodulin-dependent pathways. Endocr Rev 24: 719-736, 2003.
57. 2+ channels (Cav1.2a,b) by protein kinases. Am J Physiol Cell Physiol 281: C1743-C1756, 2001.
58. + currents and mitochondrial membrane depolarization in pulmonary artery myocyte apoptosis. Am J Physiol Lung Cell Mol Physiol 281: L887-L894, 2001.
59. + channels induces apoptosis in vascular smooth muscle cells. Am J Physiol Cell Physiol 280: C970-C979, 2001.
60. + channels in pulmonary vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 282: H184-H193, 2002.
61. 2+ currents in rat aortic smooth muscle cells in primary culture. Circ Res 79: 14-19, 1996.
62. 2+ entry. Am J Physiol Lung Cell Mol Physiol 287: L962-L969, 2004.
63. 2+ influx by binding of its scaffolding domain to transient receptor potential channel-1 in endothelial cells. Mol Pharmacol 70: 1174-1183, 2006.
64. 2+ entry via NCX reversal in ATP stimulated smooth muscle cells. Biochem Biophys Res Commun 352: 130-134, 2007.
65. 2+ channels in pulmonary arterial smooth muscle cells: a novel mechanism of hypoxic pulmonary hypertension. Circ Res 95: 496-505, 2004.
66. 2+ influx in airway smooth muscle following agonist stimulation. Respir Res 11: 168, 2010.
67. Makino A, Firth AL, Yuan JX. Endothelial and smooth muscle cell ion channels in pulmonary vasoconstriction and vascular remodeling. Compr Physiol 1: 1555-1602, 2011.
68. Mandegar M, Fung YC, Huang W, Remillard CV, Rubin LJ, Yuan JX. Cellular and molecular mechanisms of pulmonary vascular remodeling: role in the development of pulmonary hypertension. Microvasc Res 68: 75-103, 2004.
69. Mathew R, Huang J, Shah M, Patel K, Gewitz M, Sehgal PB. Disruption of endothelial-cell caveolin-1 a/raft scaffolding during development of monocrotaline-induced pulmonary hypertension. Circulation 110: 1499-1506, 2004.
70. 2+ entry in agonist-induced pulmonary vasoconstriction. Am J Physiol Lung Cell Mol Physiol 280: L870-L880, 2001.
71. 2+ entry in pulmonary artery smooth muscle cells. Cell Calcium 46: 99-106, 2009.
72. McMurtry MS, Archer SL, Altieri DC, Bonnet S, Haromy A, Harry Bonnet S, Puttagunta L, Michelakis ED. Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension. J Clin Invest 115: 1479-1491, 2005.
73. Means AR. Calcium, calmodulin and cell cycle regulation. FEBS Lett 347: 1-4, 1994.
74. 2+ channels by Ro 40-5967. Circ Res 75: 144-148, 1994.
75. Morrell NW, Adnot S, Archer SL, Dupuis J, Jones PL, MacLean MR, McMurtry IF, Stenmark KR, Thistlethwaite PA, Weissmann N, Yuan JX, Weir EK. Cellular and molecular basis of pulmonary arterial hypertension. J Am Coll Cardiol 54: S20-S31, 2009.
76. Munaron L. Calcium signalling and control of cell proliferation by tyrosine kinase receptors (review). Int J Mol Med 10: 671-676, 2002.
77. Nelson MT, Patlak JB, Worley JF, Standen NB. Calcium channels, potassium channels, and voltage dependence of arterial smooth muscle tone. Am J Physiol Cell Physiol 259: C3-C18, 1990.
78. Neveu D, Quignard JF, Fernandez A, Richard S, Nargeot J. Differential p-adrenergic regulation and phenotypic modulation of voltage-gated calcium currents in rat aortic myocytes. J Physiol 479: 171-182, 1994.
79. 2+ entry in pulmonary artery. Adv Exp Med Biol 661: 123-135, 2010.
80. 2+ entry in mouse pulmonary arterial smooth muscle cells. J Physiol 587: 2429-2442, 2009.
81. 2+ entry in mouse pulmonary arterial smooth muscle cells. Am J Physiol Cell Physiol 299: C1079-C1090, 2010.
82. 2+-ATPase (PMCA) 1 and 4 indicates a major housekeeping function for PMCA1 and a critical role in hyperactivated sperm motility and male fertility for PMCA4. J Biol Chem 279: 33742-33750, 2004.
83. Ooi CY, Wang Z, Tabima DM, Eickhoff JC, Chesler NC. The role of collagen in extralobar pulmonary artery stiffening in response to hypoxia-induced pulmonary hypertension. Am J Physiol Heart Circ Physiol 299: H1823-H1831, 2010.
84. Owsianik G, Talavera K, Voets T, Nilius B. Permeation and selectivity of TRP channels. Annu Rev Physiol 68: 685-717, 2006.
85. Patel HH, Zhang S, Murray F, Suda RY, Head BP, Yokoyama U, Swaney JS, Niesman IR, Schermuly RT, Pullamsetti SS, Thistleth-waite PA, Miyanohara A, Farquhar MG, Yuan JX, Insel PA. Increased smooth muscle cell expression of caveolin-1 and caveolae contribute to the pathophysiology of idiopathic pulmonary arterial hypertension. FASEB J 21: 2970-2979, 2007.
86. Penna A, Demuro A, Yeromin AV, Zhang SL, Safrina O, Parker I, Cahalan MD. The CRAC channel consists of a tetramer formed by Stim-induced dimerization of Orai dimers. Nature 456: 116-120, 2008.
87. Plane F, Johnson R, Kerr P, Wiehler W, Thorneloe K, Ishii K, Chen T, Cole W. Heteromultimeric Kv1 channels contribute to myogenic control of arterial diameter. Circ Res 96: 216-224, 2005.
88. Platoshyn O, Golovina VA, Bailey CL, Limsuwan A, Krick S, Juhaszova M, Seiden JE, Rubin LJ, Yuan JX. Sustained membrane depolarization and pulmonary artery smooth muscle cell proliferation. Am J Physiol Cell Physiol 279: C1540-C1549, 2000.
89. Platoshyn O, Yu Y, Golovina VA, McDaniel SS, Krick S, Li L, Wang JY, Rubin LJ, Yuan JX. Chronic hypoxia decreases KV channel expression and function in pulmonary artery myocytes. Am J Physiol Lung Cell Mol Physiol 280: L801-L812, 2001.
90. Post JM, Hume JR, Archer SL, Weir EK. Direct role for potassium channel inhibition in hypoxic pulmonary vasoconstriction. Am J Physiol Cell Physiol 262: C882-C890, 1992.
91. Pozeg ZI, Michelakis ED, McMurtry MS, Thebaud B, Wu XC, Dyck JR, Hashimoto K, Wang S, Moudgil R, Harry G, Sultanian R, Koshal A, Archer SL. In vivo gene transfer of the O2-sensitive potassium channel Kv1.5 reduces pulmonary hypertension and restores hypoxic pulmonary vasoconstriction in chronically hypoxic rats. Circulation 107: 2037-2044, 2003.
92. Putney JW. Capacitative calcium entry: from concept to molecules. Immunol Rev 231: 10-22, 2009.
93. Putney JW Jr, Poggioli J, Weiss SJ. Receptor regulation of calcium release and calcium permeability in parotid gland cells. Philos Trans R Soc Lond B Biol Sci 296: 37-45, 1981.
94. Razani B, Woodman SE, Lisanti MP. Caveolae: from cell biology to animal physiology. Pharmacol Rev 54: 431-467, 2002.
95. 2+ exchanger knockout mice. Am J Physiol Heart Circ Physiol 298: H1484-H1491, 2010.
96. 2+ channel function. J Cell Biol 169: 435-445, 2005.
97. 2+ exchanger. J Biol Chem 279: 13696-13704, 2004.
98. Rubin LJ. Diagnosis and management of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 126: 7S-10S, 2004.
99. Runo JR, Loyd JE. Primary pulmonary hypertension. Lancet 361: 1533-1544, 2003.
100. Schach C, Firth AL, Xu M, Remillard CV, Patel HH, Insel PA, Yuan JX. Regulation of pulmonary vasoconstriction by agonists and caveolae. Exp Lung Res 34: 195-208, 2008.
101. Scherer PE, Okamoto T, Chun M, Nishimoto I, Lodish HF, Lisanti MP. Identification, sequence, and expression of caveolin-2 defines a caveolin gene family. Proc Natl Acad Sci USA 93: 131-135, 1996.
102. Sheng M, McFadden G, Greenberg ME. Membrane depolarization and calcium induce c-fos transcription via phosphorylation of transcription factor CREB. Neuron 4: 571-582, 1990.
103. 2+ pool content is linked to control of cell growth. Proc Natl Acad Sci USA 90: 4986-4990, 1993.
104. Simonneau G, Robbins IM, Beghetti M, Channick RN, Delcroix M, Denton CP, Elliott CG, Gaine SP, Gladwin MT, Jing ZC, Krowka MJ, Langleben D, Nakanishi N, Souza R. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 54: S43-S54, 2009.
105. + current in rat pulmonary artery muscle cells. Am J Physiol Heart Circ Physiol 266: H365-H370, 1994.
106. Somlyo AP, Somlyo AV. Signal transduction and regulation in smooth muscle. Nature 372: 231-236, 1994.
107. Somlyo AP, Somlyo AV. Smooth muscle: excitation-contraction coupling, contractile regulation, and the cross-bridge cycle. Alcohol Clin Exp Res 18: 138-143, 1994.
108. 2+ entry in pulmonary artery smooth muscle cells from patients with idiopathic pulmonary arterial hypertension. Pulm Circ 1: 84-94, 2011.
109. Song MY, Makino A, Yuan JX. Role of reactive oxygen species and redox in regulating the function of transient receptor potential channels. Antioxid Redox Signal 15: 1549-1565, 2010.
110. Song MY, Yuan JX. Introduction to TRP channels: structure, function, and regulation. Adv Exp Med Biol 661: 99-108, 2010.
111. Stenmark KR, Davie N, Frid M, Gerasimovskaya E, Das M. Role of the adventitia in pulmonary vascular remodeling. Physiology (Bethesda) 21: 134-145, 2006.
112. Stenmark KR, Meyrick B, Galie N, Mooi WJ, McMurtry IF. Animal models of pulmonary arterial hypertension: the hope for etiological discovery and pharmacological cure. Am J Physiol Lung Cell Mol Physiol 297: L1013-L1032, 2009.
113. 2+ entry in endothelial cells. Am J Physiol Cell Physiol 296: C403-C413, 2009.
114. Suzuki H, Twarog BM. Membrane properties of smooth muscle cells in pulmonary arteries of the rat. Am J Physiol Heart Circ Physiol 242: H900-H906, 1982.
115. Suzuki H, Twarog BM. Membrane properties of smooth muscle cells in pulmonary hypertensive rats. Am J Physiol Heart Circ Physiol 242: H907-H915, 1982.
116. 2+ entry and attenuates pulmonary artery smooth muscle cell proliferation. Am J Physiol Lung Cell Mol Physiol 283: L144-L155, 2002.
117. + entry. Biochem Biophys Res Commun 357: 1177-1182, 2007.
118. 2+-dependent activation of endothelial ni-tric-oxide synthase. J Biol Chem 274: 29529-29535, 1999.
119. 2+ channels in mesenteric veins: mechanism of venous smooth muscle resistance to calcium channel blockers. Circ Res 106: 739-747, 2010.
120. Tsien RW, Tsien RY. Calcium channels, stores, oscillations. Annu Rev Cell Biol 6: 715-760, 1990.
121. Tuder RM, Groves B, Badesch DB, Voelkel NF. Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension. Am J Pathol 144: 275-285, 1994.
122. Tuder RM, Marecki JC, Richter A, Fijalkowska I, Flores S. Pathology of pulmonary hypertension. Clin Chest Med 28: 23-42, 2007.
123. Vachiery JL, Brimioulle S, Crasset V, Naeije R. False-positive diagnosis of pulmonary hypertension by Doppler echocardiography. Eur RespirJ 12: 1476-1478, 1998.
124. 2+/NFAT pathway is involved in the anti-proliferative effect of sildenafil on pulmonary artery smooth muscle cells. Respir Res 10: 123, 2009.
125. + channel alpha subunits in pulmonary artery smooth muscle cells. J Clin Invest 100: 2347-2353, 1997.
126. Ward JP, McMurtry IF. Mechanisms of hypoxic pulmonary vasoconstriction and their roles in pulmonary hypertension: new findings for an old problem. Curr Opin Pharmacol 9: 287-296, 2009.
127. Weissmann N, Dietrich A, Fuchs B, Kalwa H, Ay M, Dumitrascu R, Olschewski A, Storch U, Mederos Schnitzler M., Ghofrani H.A, Schermuly RT, Pinkenburg O, Seeger W, Grimminger F, Guder-mann T. Classical transient receptor potential channel 6 (TRPC6) is essential for hypoxic pulmonary vasoconstriction and alveolar gas exchange. Proc NatlAcad Sci USA 103: 19093-19098, 2006.
128. Wijetunge S, Lymn JS, Hughes AD. Effects of protein tyrosine kinase inhibitors on voltage-operated calcium channel currents in vascular smooth muscle cells and pp60 (c-src) kinase activity. Br J Pharmacol 129: 1347-1354, 2000.
129. 2+-activated Cl channels in rabbit pulmonary arterial smooth muscle cells. Br J Pharmacol 158: 1356-1365, 2009.
130. Yeromin AV, Zhang SL, Jiang W, Yu Y, Safrina O, Cahalan MD. Molecular identification of the CRAC channel by altered ion selectivity in a mutant of Orai. Nature 443: 226-229, 2006.
131. Yi ES, Kim H, Ahn H, Strother J, Morris T, Masliah E, Hansen LA, Park K, Friedman PJ. Distribution of obstructive intimal lesions and their cellular phenotypes in chronic pulmonary hypertension. A morpho-metric and immunohistochemical study. Am J Respir Crit Care Med 162: 1577-1586, 2000.
132. Yu Y, Fantozzi I, Remillard CV, Landsberg JW, Kunichika N, Platoshyn O, Tigno DD, Thistlethwaite PA, Rubin LJ, Yuan JX. Enhanced expression of transient receptor potential channels in idiopathic pulmonary arterial hypertension. Proc Natl Acad Sci USA 101: 13861-13866, 2004.
133. Yu Y, Keller SH, Remillard CV, Safrina O, Nicholson A, Zhang SL, Jiang W, Vangala N, Landsberg JW, Wang JY, Thistlethwaite PA, Channick RN, Robbins IM, Loyd JE, Ghofrani HA, Grimminger F, Schermuly RT, Cahalan MD, Rubin LJ, Yuan JX. A functional single-nucleotide polymorphism in the TRPC6 gene promoter associated with idiopathic pulmonary arterial hypertension. Circulation 119: 2313-2322, 2009.
134. Yu Y, Sweeney M, Zhang S, Platoshyn O, Landsberg J, Rothman A, Yuan JX. PDGF stimulates pulmonary vascular smooth muscle cell proliferation by upregulating TRPC6 expression. Am J Physiol Cell Physiol 284: C316-C330, 2003.
135. + channels in pulmonary artery smooth muscle cells of patients with primary pulmonary hypertension. Circulation 98: 1400-1406, 1998.
136. Yuan JX, Rubin LJ. Pathogenesis of pulmonary arterial hypertension: the need for multiple hits. Circulation 111: 534-538, 2005.
137. 2+]i in pulmonary arterial myocytes. Circ Res 77: 370-378, 1995.
138. Yuan XJ, Goldman WF, Tod ML, Rubin LJ, Blaustein MP. Hypoxia reduces potassium currents in cultured rat pulmonary but not mesenteric arterial myocytes. Am J Physiol Lung Cell Mol Physiol 264: L116-L123, 1993.
139. Yuan XJ, Tod ML, Rubin LJ, Blaustein MP. Contrasting effects of hypoxia on tension in rat pulmonary and mesenteric arteries. Am J Physiol Heart Circ Physiol 259: H281-H289, 1990.
140. + channel gene transcription in primary pulmonary hypertension. Lancet 351: 726-727, 1998.
141. 2+ channel current and lowers blood pressure. Am J Physiol Heart Circ Physiol 298: H1472-H1483, 2010.
142. 2+ entry in pulmonary artery smooth muscle cells from patients with idiopathic pulmonary arterial hypertension. Am J Physiol Cell Physiol 292: C2297-C2305, 2007.
143. Zhang S, Fantozzi I, Tigno DD, Yi ES, Platoshyn O, Thistlethwaite PA, Kriett JM, Yung G, Rubin LJ, Yuan JX. Bone morphogenetic proteins induce apoptosis in human pulmonary vascular smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 285: L740-L754, 2003.
144. 2+ in cultured human pulmonary artery smooth muscle cells. Am J Physiol Cell Physiol 288: C245-C252, 2005.
145. 2+ store to the plasma membrane. Nature 437: 902-905, 2005.
146. Zhao YY, Liu Y, Stan RV, Fan L, Gu Y, Dalton N, Chu PH, Peterson K, Ross J Jr, Chien KR. Defects in caveolin-1 cause dilated cardiomyopathy and pulmonary hypertension in knockout mice. Proc Natl Acad Sci USA 99: 11375-11380, 2002.
147. Zhao YY, Zhao YD, Mirza MK, Huang JH, Potula HH, Vogel SM, Brovkovych V, Yuan JX, Wharton J, Malik AB. Persistent eNOS activation secondary to caveolin-1 deficiency induces pulmonary hypertension in mice and humans through PKG nitration. J Clin Invest 119: 2009-2018, 2009.